Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Tuesday, September 30

8:20 AM - 8:30 AM PT

291 - A Safety Study of Intraoperative Radiation Therapy Following Stereotactic Body Radiation Therapy and Multi-Agent Chemotherapy in the Treatment of Localized Pancreatic Adenocarcinoma
Speaker: Reddy, Abhinav, MD - Northside Hospital, Atlanta, GA
8:20 AM - 8:30 AM PT

296 - Recovering Dose Dynamics and Dose Rate Volume Histograms in UHDR PBS Proton Therapy Using Scintillation Array Dosimetry
Speaker: Vasyltsiv, Roman, BS - Dartmouth College, Hanover, NH
8:25 AM - 8:30 AM PT

1046 - The Role of TP53 in Nodal Metastasis: A Molecular Guide for Neck Management in Oral Cavity Cancer
Speaker: Lee, Victor, MD, BS - Yale New Haven Hospital, Middletown, CT
8:25 AM - 8:30 AM PT

1052 - Comparison of Image Guided Thermal Ablation and Stereotactic Body Radiation Therapy for Primary Non-Small Cell Lung Cancer
Speaker: Nikitas, John, MD - University of Pennsylvania, Philadelphia, PA
8:25 AM - 8:30 AM PT

2724 - Predictive Value of Plasma Exosomal miRNAs and mRNAs for Acute Tumor Response in Locally Advanced Cervical Cancer Undergoing Concurrent Chemoradiotherapy
Speaker: Cho, Oyeon, MD, PhD - Ajou University Medical Center, suwon, gyunggi
8:30 AM - 8:35 AM PT

1047 - Proposal for Future Refinement of N Category in Version-Nine of AJCC/UICC TNM Staging System for Nasopharyngeal Carcinoma based on the International Consensus Recommendations for Diagnosing Extranodal Extension
Speaker: Zhong, Jing, MD, PhD - Fujian Cancer Hospital, Fuzhou, Fujian
8:30 AM - 8:35 AM PT

1053 - Optimizing Blood-Based Genomic Characterization of Oligometastatic Non-Small Cell Lung Cancer Patients
Speaker: Choi, Ariel, MD - Wake Forest Baptist Medical Center, Winston Salem, NC
8:30 AM - 8:40 AM PT

282 - Early-Stage Breast Cancer with Low Genomic Risk: Optimizing Adjuvant Therapy
Speaker: Miller, David, MD, MS - Memorial Sloan Kettering Cancer Center, New York, NY
8:30 AM - 8:40 AM PT

287 - Predictive Factors for Survival after Reirradiation of IDH Wild Type High Grade Glioma
Speaker: Petersen, John, DO - Wake Forest Baptist Medical Center, Winston Salem, NC
8:30 AM - 8:40 AM PT

292 - Maximal Ablative Irradiation because of Encasement for Patients with Potentially Resectable Locally Advanced Pancreatic Cancer: Final Results of Phase II MAIBE Trial
Speaker: Reyngold, Marsha, MD, PhD - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
8:30 AM - 8:40 AM PT

297 - Bridging the Gap between the Treatment Plan and In Vivo Dosimetry through Clinical Scintillation Imaging
Speaker: Clark, Megan, PhD, BS - Stanford University, Stanford, CA
8:30 AM - 8:50 AM PT

Question and Answers
Speaker: Lin, Lilie, MD, FASTRO - University of Texas MD Anderson Cancer Center, Houston, Texas